Dr Peter Schmidt
Nuclear Medicine
Qbiotics
Australia
Biography
Dr Peter Schmidt holds a Bachelor of Science (Hons) and a PhD in Nuclear Medicine. Dr Schmidt has considerable expertise in the development of drug candidates for submission to both the Therapeutic Goods Administration (TGA) in Australia and the FDA in the USA up to Clinical Phase III including (i) preparation of CMC and Preclinical data packages required for IND submissions, and (ii) the clinical practices required during Clinical Phase I and II trials.
Research Interest
Nuclear Medicine
